Latest News in the pharma Industry

Research & Development

Daiichi Sankyo to reorganise its R&D structure

Daiichi Sankyo to reorganise its R&D structure

8 Dec 2015

Company's research subsidiary, U3 Pharma, to close.

Read more 
Stretchy hydrogel “Band-Aid” senses, lights up, delivers medicine

Stretchy hydrogel “Band-Aid” senses, lights up, delivers medicine

7 Dec 2015

Water-based “Band-Aid” senses temperatre, lights up, and delivers medicine to the skin.

Read more 
Novartis highlights new CTL019 Phase II data demonstrating 93% complete remission in pediatric patients with r/r ALL

Novartis highlights new CTL019 Phase II data demonstrating 93% complete remission in pediatric patients with r/r ALL

7 Dec 2015

55 of 59 patients experienced complete remissions in a single-arm study of the largest investigational CART therapy in children and young adults.

Read more 
GlycoMimetics poster shows GMI-1271 reverses drug resistance in multiple myeloma models

GlycoMimetics poster shows GMI-1271 reverses drug resistance in multiple myeloma models

6 Dec 2015

GlycoMimetics to initiate myeloma trial in mid-2016.

Read more 
Amgen's first biosimilar marketing authorization application submitted to EMA for ABP 501

Amgen's first biosimilar marketing authorization application submitted to EMA for ABP 501

4 Dec 2015

Supported by Phase III studies in moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.

Read more 
Propeller Health announces development agreement and R&D collaboration with GSK to develop a digital sensor for the Ellipta inhaler

Propeller Health announces development agreement and R&D collaboration with GSK to develop a digital sensor for the Ellipta inhaler

1 Dec 2015

Collaboration reinforces Propeller Health's leadership in respiratory digital health and creates a joint opportunity to advance treatment of respiratory disease through digital innovation.

Read more 
Novozymes' Veltis half-life extension technology embraced by Paras Biopharmaceuticals to develop new biobetter

Novozymes' Veltis half-life extension technology embraced by Paras Biopharmaceuticals to develop new biobetter

30 Nov 2015

Paras Biopharmaceuticals partners with Novozymes in a feasibility study using Veltis technology to develop an improved version of a leading osteoporosis treatment.

Read more 
GSK announces start of Phase III study of sirukumab in giant cell arteritis

GSK announces start of Phase III study of sirukumab in giant cell arteritis

30 Nov 2015

Study approach will specifically answer whether treatment with sirukumab can reduce the duration of steroid treatment typical in clinical practice.

Read more 
Sosei subsidiary Heptares to collaborate with Pfizer on GPCR targets across multiple therapeutic areas

Sosei subsidiary Heptares to collaborate with Pfizer on GPCR targets across multiple therapeutic areas

30 Nov 2015

Pfizer will be responsible for developing and commercialising any potential therapeutic agents (small molecules or biologics derived from StaR antigens) for each target and will have exclusive global rights to any potential resulting agents.

Read more 
ReproCELL acquires Biopta to expand its drug discovery services

ReproCELL acquires Biopta to expand its drug discovery services

27 Nov 2015

Acquisition aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services.

Read more 
Epigenomics appeals recent FDA request for additional information

Epigenomics appeals recent FDA request for additional information

27 Nov 2015

Company believes that an approval for the intended use of Epi proColon is warranted based on the data that has been submitted to date.

Read more 
BMS announces regulatory update for Opdivo in advanced melanoma

BMS announces regulatory update for Opdivo in advanced melanoma

27 Nov 2015

Read more